HD Research - Legent Orthopedic Hospital

Evolution Research Group

Postoperative Pain

Acetaminophen

Bupivacaine HCl

Methocarbamol

Arthritis Innovation Corporation

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This is a Phase 3, randomized, double blind, multicenter study to evaluate the analgesic efficacy and safety of a single intra-articular dose of F14 (625 mg sustained release celecoxib) administered concurrent with multimodal analgesia in patients undergoing total knee replacement surgery, compared to multimodal analgesia alone.

A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement

Evolution Research Group | HD Research - Legent Orthopedic Hospital

Site insights

Work at this site?

Active trials

A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement

Trial sponsors